We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Revises MOU on Interstate Distribution of Compounded Drugs
FDA Revises MOU on Interstate Distribution of Compounded Drugs
FDA Commissioner Scott Gottlieb announced a revised agreement between the agency and states on interstate distribution of compounded drugs, responding to concerns that the existing distribution limits are too low.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor